(Q47818018)

English

Analysis of remobilization success in patients undergoing autologous stem cell transplants who fail an initial mobilization: risk factors, cytokine use and cost

scientific article published in May 2004

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

5 February 2018

http://europepmc.org/abstract/MED/15064690

Analysis of remobilization success in patients undergoing autologous stem cell transplants who fail an initial mobilization: risk factors, cytokine use and cost (English)

1 reference

Europe PubMed Central

5 February 2018

http://europepmc.org/abstract/MED/15064690

author name string

Boeve S

1

1 reference

Europe PubMed Central

5 February 2018

http://europepmc.org/abstract/MED/15064690

Strupeck J

2

1 reference

Europe PubMed Central

5 February 2018

http://europepmc.org/abstract/MED/15064690

Creech S

3

1 reference

Europe PubMed Central

5 February 2018

http://europepmc.org/abstract/MED/15064690

Stiff PJ

4

1 reference

Europe PubMed Central

5 February 2018

http://europepmc.org/abstract/MED/15064690

language of work or name

0 references

publication date

1 May 2004

1 reference

Europe PubMed Central

5 February 2018

http://europepmc.org/abstract/MED/15064690

Bone Marrow Transplantation

1 reference

Europe PubMed Central

5 February 2018

http://europepmc.org/abstract/MED/15064690

33

1 reference

Europe PubMed Central

5 February 2018

http://europepmc.org/abstract/MED/15064690

10

1 reference

Europe PubMed Central

5 February 2018

http://europepmc.org/abstract/MED/15064690

997-1003

1 reference

Europe PubMed Central

5 February 2018

http://europepmc.org/abstract/MED/15064690

https://scigraph.springernature.com/pub.10.1038/sj.bmt.1704486

0 references

Management strategies for the hard-to-mobilize patient

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704486

21 January 2018

Factors influencing collection and engraftment of CD34+ cells in patients with breast cancer following high-dose chemotherapy and autologous peripheral blood progenitor cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704486

21 January 2018

Economic considerations in the use of peripheral blood progenitor cells to support high-dose chemotherapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704486

21 January 2018

Factors influencing collection of peripheral blood progenitor cells following high-dose cyclophosphamide and granulocyte colony-stimulating factor in patients with multiple myeloma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704486

21 January 2018

Successful mobilization of peripheral blood stem cells in heavily pretreated myeloma patients with G-CSF alone

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704486

21 January 2018

Peripheral blood progenitor cell collections in multiple myeloma: predictors and management of inadequate collections.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704486

21 January 2018

Second attempts at mobilization of peripheral blood stem cells in patients with initial low CD34+ cell yields.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704486

21 January 2018

Treatment of normal individuals with granulocyte-colony-stimulating factor: donor experiences and the effects on peripheral blood CD34+ cell counts and on the collection of peripheral blood stem cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704486

21 January 2018

G-CSF-mobilized peripheral blood progenitor cells for allogeneic transplantation: safety, kinetics of mobilization, and composition of the graft.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704486

21 January 2018

High-dose therapy followed by autologous peripheral-blood stem-cell transplantation for patients with Hodgkin's disease and non-Hodgkin's lymphoma using unprimed and granulocyte colony-stimulating factor-mobilized peripheral-blood stem cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704486

21 January 2018

High-versus standard-dose filgrastim (rhG-CSF) for mobilization of peripheral-blood progenitor cells from allogeneic donors and CD34(+) immunoselection.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704486

21 January 2018

Phase I/II study of combined granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor administration for the mobilization of hematopoietic progenitor cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704486

21 January 2018

A combination of low-dose cyclophosphamide and colony-stimulating factors is more cost-effective than granulocyte-colony-stimulating factors alone in mobilizing peripheral blood stem and progenitor cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704486

21 January 2018

Economic analysis of a randomized clinical trial to compare filgrastim-mobilized peripheral-blood progenitor-cell transplantation and autologous bone marrow transplantation in patients with Hodgkin's and non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704486

21 January 2018

A study of ovarian cancer patients treated with dose-intensive chemotherapy supported with peripheral blood progenitor cells mobilised by filgrastim and cyclophosphamide

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704486

21 January 2018

Recombinant human thrombopoietin: basic biology and evaluation of clinical studies

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704486

21 January 2018

A randomized phase 2 study of PBPC mobilization by stem cell factor and filgrastim in heavily pretreated patients with Hodgkin's disease or non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704486

7 January 2021

based on heuristic

inferred from DOI database lookup

Successful PBSC mobilization with high-dose G-CSF for patients failing a first round of mobilization

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704486

7 January 2021

based on heuristic

inferred from DOI database lookup

Engraftment and outcomes of patients receiving myeloablative therapy followed by autologous peripheral blood stem cells with a low CD34+ cell content

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704486

7 January 2021

based on heuristic

inferred from DOI database lookup

Bone marrow reconstitution after high-dose chemotherapy and autologous peripheral blood progenitor cell transplantation: effect of graft size

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704486

7 January 2021

based on heuristic

inferred from DOI database lookup

Daily measurements of blood CD34+ cells after stem cell mobilization predict stem cell yield and posttransplant hematopoietic recovery

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704486

7 January 2021

based on heuristic

inferred from DOI database lookup

Relationship of CD34+ cell dose to early and late hematopoiesis following autologous peripheral blood stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704486

7 January 2021

based on heuristic

inferred from DOI database lookup

Factors associated with successful mobilization of peripheral blood progenitor cells in 200 patients with lymphoid malignancies

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704486

7 January 2021

based on heuristic

inferred from DOI database lookup

Factors that influence collection and engraftment of autologous peripheral-blood stem cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704486

7 January 2021

based on heuristic

inferred from DOI database lookup

Peripheral blood stem cells (PBSCs) collected after recombinant granulocyte colony stimulating factor (rhG-CSF): an analysis of factors correlating with the tempo of engraftment after transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704486

7 January 2021

based on heuristic

inferred from DOI database lookup

Scoring system for the prediction of successful peripheral blood stem cell (PBSC) collection in non-Hodgkin's lymphoma (NHL): application in clinical practice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704486

7 January 2021

based on heuristic

inferred from DOI database lookup

Characterization and outcome of "hard to mobilize"' lymphoma patients undergoing autologous stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704486

7 January 2021

based on heuristic

inferred from DOI database lookup

Fludarabine-containing regimens severely impair peripheral blood stem cells mobilization and collection in acute myeloid leukaemia patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704486

7 January 2021

based on heuristic

inferred from DOI database lookup

Predictive factors for peripheral-blood progenitor-cell collections using a single large-volume leukapheresis after cyclophosphamide and granulocyte-macrophage colony-stimulating factor mobilization

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704486

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy of further attempts to mobilize CD34+ peripheral stem cells with alternative procedures after primary failure

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704486

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy and toxicity of a high-dose G-CSF schedule for peripheral blood progenitor cell mobilization in healthy donors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704486

7 January 2021

based on heuristic

inferred from DOI database lookup

Factors influencing G-CSF-mediated mobilization of hematopoietic progenitor cells during steady-state hematopoiesis in patients with malignant lymphoma and multiple myeloma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704486

7 January 2021

based on heuristic

inferred from DOI database lookup

Mobilization and harvesting of peripheral blood stem cells: randomized evaluations of different doses of filgrastim

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704486

7 January 2021

based on heuristic

inferred from DOI database lookup

Use of concurrent G-CSF + GM-CSF vs G-CSF alone for mobilization of peripheral blood stem cells in children with malignant disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704486

7 January 2021

based on heuristic

inferred from DOI database lookup

Mobilization, collection, and processing of autologous peripheral blood stem cells: development of a clinical process with associated costs

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704486

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/SJ.BMT.1704486

1 reference

Europe PubMed Central

5 February 2018

http://europepmc.org/abstract/MED/15064690

1 reference

Europe PubMed Central

5 February 2018

http://europepmc.org/abstract/MED/15064690

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q47818018&oldid=2172088913"